Immunoassays are biochemical assays used to detect an analyte’s presence, either antibody or antigen, using labeled antibodies as the analytical reagent. For certain infectious diseases, including Lyme disease, cryptococcal meningitis, and syphilis, antibody and antigen detection by immunoassays is the primary means by which the infection is established. Due to their ease of use, rapid turnaround time, and generally high specificity, immunoassays are increasingly becoming available for point‐of‐care testing. The rising burden of infectious diseases across the globe has increased, which, in turn, is expected to result in the growing demand for safe & effective assays.
Download Free Sample Report Copy Here : https://www.meticulousresearch.com/download-sample-report/cp_id=4982
Immunoassay technologies utilize antigen-antibody reactions for the detection of causative agents and immunoassays have been one of the fast-growing clinical diagnostics technologies. Thus, the increasing prevalence of infectious diseases across the globe offer lucrative opportunities for the manufacturers, enabling the launch of novel immunoassay products, which would further help in the timely identification of various diseases
In efforts to deliver effective immunoassay solutions, manufacturers have started developing tests that require minimal time for testing and are more advanced than the available tests. Meticulous Research®, in its latest publication on Immunoassay Market, states that the global market is expected to grow at a CAGR of 7.5% from 2021 to 2028 to reach $46.5 billion by 2028.
Scope of the Report:
Immunoassays Market, by Product & Solution
- Immunoassay Kits and Reagents
- Elisa Kits and Reagents
- Rapid Test Kits and Reagents
- Western Blot Kits and Reagents
- Elispot Kits and Reagents
- Other Immunoassay Kits and Reagents
- Immunoassay Analyzers
- Immunoassay Software and Services
(Other immunoassay kits and reagents comprises radioimmunoassay, microarray immunoassays, immunohistochemistry assays, bead-based immunoassays, and multiplex microarray assays)
Immunoassays Market, by Platform
- Chemiluminescence Immunoassay
- Fluorescence Immunoassay
- Colorimetric Immunoassay
- Radioimmunoassay
- Other Immunoassay Platforms
(Other immunoassay platforms comprise turbidimetric immunoassays, chromatographic immunoassays, microarray immunoassays, immunohistochemistry, and counting immunoassays)
Immunoassays Market, by Application
- Infectious Diseases
- Oncology
- Endocrinology
- Cardiology
- Bone and Mineral Diseases
- Autoimmune Disorders
- Other Applications
(Other applications comprise toxicology, hematology, neonatal testing, allergy, and gastrology.)
Immunoassay Market, by End User
- Diagnostics Reference Laboratories
- Hospitals and Clinics
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Other End Users
(Other end users comprise nursing homes, ambulatory care centers, blood banks, and home healthcare agencies)
Immunoassays Market, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Australia
- Indonesia
- Rest of APAC (RoAPAC)
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
To gain more insights into the market with a detailed table of content and figures, click here : https://www.meticulousresearch.com/product/immunoassay-market-4982
Factors driving the growth of the immunoassays market include the increasing prevalence of various chronic and infectious diseases, technological advancements, increasing use of immunoassays in oncology and drug & alcohol testing, and the emergence of COVID-19. Moreover, the increasing epidemic potentials, integration of microfluidics technology into immunoassays, and emerging economies offer significant growth opportunities for the players operating in this market. On the other hand, unfavorable reimbursement scenarios and stringent regulatory requirements are restraining this market’s growth to a certain extent.
To provide efficient analysis, Meticulous Research® has segmented this market by Product & Solutions (Immunoassay Kits {ELISA, Rapid Tests, Western Blot, ELISPOT, Others}, Immunoassay Platform, Software & Services), Platform (Chemiluminescence, Radioimmunoassay, Fluorescence Immunoassay, Colorimetric Immunoassays, Other Platforms), Application (Infectious Diseases, Cardiology, Endocrinology, Oncology, Bone & Mineral Disorders, Autoimmune Diseases, Other Applications), End User (Hospital & Clinics, Diagnostic Reference Laboratories, Pharmaceutical and Biotechnology Companies, Research & Academic Laboratories, Other End Users), and Geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).
Geographically, North America accounted for the largest share of the immunoassays market in 2020, followed by Europe and Asia-Pacific. However, Asia-Pacific is slated to register the highest growth during the forecast period due to the increasing prevalence of infectious diseases and cancer.
Based on product and solution, the immunoassay kits and reagents segment accounted for the largest share in 2020 due to the increasing number of immunoassay tests, technological advancements in ELISpot assay kits, and increasing demand for immunoassay-based COVID-19 testing products.
Based on platform, the chemiluminescence immunoassays segment accounted for the largest share of the immunoassays market in 2020 owing to the increasing adoption of chemiluminescence assays in clinical diagnostics & research applications and in pharmaceutical analysis.
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business : https://www.meticulousresearch.com/speak-to-analyst/cp_id=4982
Key Players:
The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on some of the key players in this market, including F. Hoffman La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Ortho Clinical Diagnostics (U.S.), DiaSorin SpA (Italy), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Quidel Corporation (U.S.), and Bio-Techne Corporation (U.S.), among others.
Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here-https://www.meticulousresearch.com/custom-research
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Media Contact
Company Name: Meticulous Market Research Pvt Ltd
Contact Person: Khushal Bombe
Email: Send Email
Phone: +1 646-781-8004
Address:1267 Willis St, Ste 200 Redding, California, 96001, U.S.
Country: United States
Website: www.meticulousresearch.com